Researchers at Rochester and Maryland describe a novel cross-coupling reaction.
If there were a classroom full of all the transition metals that could be used as catalysts for complex pharmaceutical reactions, iron would be the most promising but most unruly member.
However, researchers at the and the University of Maryland have created and characterized a new kind of reaction that could potentially bring iron to the front of the class, enabling faster, less expensive synthesis of previously difficult to make, drug-like compounds in a single step. They report .
鈥淭his is a tremendous leap forward in developing effective and practical iron-based reactions that the pharmaceutical industry could utilize,鈥� says , the Marshall D. Gates, Jr. Professor of Chemistry at Rochester, whose research group collaborated with that of associate professor of chemistry at Maryland, before Gutierrez moved to Texas A&M in August 2021.
Iron: a better catalyst than palladium for chemical synthesis
So-called transition-metal catalyzed cross-coupling reactions are among the most widely used methods for chemical synthesis. The transition metal catalyst often used by industry and academic labs for these reactions is palladium. Palladium works well, but it鈥檚 rare, expensive, and toxic鈥攚hich is why the Neidig and Gutierrez labs have been working to generate iron alternatives.
Iron鈥攖hough abundant, cheap, and relatively nontoxic鈥攈as been underdeveloped in part because when it is bound to carbon in these reactions, the resulting organoiron compound can be very unstable and challenging to control.
While most cross couplings used in these reactions involve putting two molecules together, lead author Lei Liu, of Gutierrez鈥檚 group, managed to create three-component couplings, increasing the reaction鈥檚 potential for bonding with multiple compounds. Co-lead author Maria Camila Aguilera, a PhD student in Neidig鈥檚 group, then painstakingly analyzed exactly how the reaction works.
Part of Aguilera鈥檚 work involved recreating the exact crystal structure of each of the four 鈥渟pecies鈥� of iron used in the reaction鈥攊n effect, creating a photo of each. She then characterized each of the species to determine which started the reaction, and the roles played by the other three at different stages of the reaction.
鈥淚t was a very challenging project,鈥� says the fourth-year PhD student who came to Rochester after completing a BS in chemistry at the Universidad Nacional de Colombia. 鈥�But I was very excited about it because it allowed me to really dig into a very different type of chemistry.鈥�
Neidig says that Aguilera used an array of spectroscopy tools and a unique cryogenic infrastructure that allowed lab to 鈥渟tudy unstable organoiron compounds that very few chemistry labs in the world can.鈥� Her analysis 鈥渟ets the framework to continue the development of iron-based reactions in a rational, mechanistically driven way,鈥� he adds.
A promising advance in drug development
What are the prospects for implementation in drug development?
鈥淚 think it鈥檚 a reaction that will be attractive to pharmaceutical companies,鈥� Neidig says.
鈥淭he reaction might require more tweaking and development,鈥� he adds. But when it comes to that task, 鈥渢he fundamental mechanistic framework we established will be so important in helping people think about how to make this system better and more efficient.鈥�
Both Aguilera and Neidig praised the close working relationship that developed with Gutierrez鈥檚 lab, especially given the scarcity of labs willing to work with iron catalyzed cross-coupling reactions because of the high risks and low rewards.
鈥淥svaldo is an incredible collaborator,鈥� Aguilera says.聽鈥淗e is very willing to share his knowledge, and so it was a pleasure to work with him.鈥�
The project is supported with funding from the National Institutes of Health and the National Science Foundation.
Read more
鈥楬igh risk鈥� project uses quantum science to unlock new chemical reactions
Rochester scientists have secured national funding for a multi-institutional research effort that could alter the basic rules of chemistry.
Pulsed lasers in liquids speed up the hunt for effective catalysts
In the most comprehensive, up-to-date survey of a technology that was first developed in 1987, Rochester researchers have documented the advantages of using the pulsed-laser-in-liquids technique over traditional wet laboratory methods.
COVID-19: What鈥檚 RNA research got to do with it?
RNA research at the 人妻少妇专区 provides an important foundation for developing antiviral drugs, vaccines, and other therapeutics to disrupt the global spread of coronavirus.
